Discover
BRNS
Barinthus Biotherapeutics plc
0.60
92 x 0.50
49 x 0.69
bid
ask
+
0.04
6.57%
12:08 PM
timesize
| Ytd | -14.29% | |
| 1y | -47.37% |
0.58
day range
0.60
0.51
52 week range
1.83
| Open | 0.60 | Prev Close | 0.56 | Low | 0.58 | High | 0.60 | Mkt Cap | 24.51M |
| Vol | 3.93K | Avg Vol | 76.24K | EPS | -1.03 | P/E | -0.58 | Forward P/E | -0.62 |
| Beta | -0.39 | Short Ratio | 0.19 | Inst. Own | 46.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 0.64 | 200-d Avg | 0.70 | 1yr Est | 7.25 |
| Income Statement | |||
| Operating Expenses | 11.02M | ||
| Research and Development Expense | 3.92M | ||
| Selling, General and Administrative Expense | 7.10M | ||
| Operating Income | -11.02M | ||
| Interest Expense | 14.00K | ||
| Income Tax Expense | -23.00K | ||
| Net Income | -10.58M | ||
| Net Income Common Stock | -10.58M | ||
| Net Income Common Stock (USD) | -10.58M | ||
| Consolidated Income | -10.60M | ||
| Net Income to Non-Controlling Interests | -19.00K | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -10.59M | ||
| Earning Before Interest & Taxes (USD) | -10.59M | ||
| Weighted Average Shares | 40.85M | ||
| Weighted Average Shares Diluted | 40.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 59.63M | ||
| Cash and Equivalents (USD) | 59.63M | ||
| Current Assets | 63.27M | ||
| Property, Plant & Equipment Net | 4.66M | ||
| Total Assets | 81.89M | ||
| Debt Current | 1.72M | ||
| Total Debt | 10.30M | ||
| Current Liabilities | 11.42M | ||
| Debt Non-Current | 8.57M | ||
| Total Liabilities | 24.76M | ||
| Accumulated Retained Earnings (Deficit) | -320.21M | ||
| Accumulated Other Comprehensive Income | -17.74M | ||
| Shareholders Equity | 57.07M | ||
| Shareholders Equity (USD) | 57.07M | ||
| Assets Non-Current | 18.62M | ||
| Total Debt (USD) | 10.30M | ||
| Deferred Revenue | 335.00K | ||
| Goodwill and Intangible Assets | 13.05M | ||
| Liabilities Non-Current | 13.34M | ||
| Trade and Non-Trade Payables | 535.00K | ||
| Tax Assets | 1.28M | ||
| Tax Liabilities | 215.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.56M | ||
| Capital Expenditure | 61.00K | ||
| Net Cash Flow from Investing | 61.00K | ||
| Net Cash Flow from Operations | -8.09M | ||
| Effect of Exchange Rate Changes on Cash | 471.00K | ||
| Share Based Compensation | 433.00K | ||